CARDIOLOGY: 2021 Clinical Focus Collection
Clinical Focus Collection: Cardiology
Table of Contents
Videos – Expert Interviews
UCSF Cardiologist Tells Hypertension Self-management Study Success Story
Alexis Beatty, MD, MAS
Associate Professor of Epidemiology and Biostatistics,
Associate Professor of Medicine,
University of California, San Francisco
San Francisco, CA
Preventive Cardiology after Framingham: Nathan D. Wong, PhD, MPH, Details the Evolution
Nathan Wong, PhD
Professor and Director
Heart Disease Prevention Program, Division of Cardiology
University of California, Irvine
Keith C. Ferdinand, MD: COVID-19, Obesity, and the African American Community
Keith C. Ferdinand
Gerald S. Berenson Endowed Chair in Preventive Cardiology
Professor of Medicine, Tulane University School of Medicine,
Tulane Heart and Vascular Institute,
New Orleans, LA
Gregory Marcus, MD, MAS, Reviews the Coffee and Real-time Atrial & Ventricular Ectopy (CRAVE) Trial
Gregory M. Marcus, MD, MAS
Professor of Medicine, University of California, San Francisco,
Associate Chief of Cardiology for Research, UCSF Health,
Inaugural Endowed Professor of Atrial Fibrillation Research
George Bakris, MD: Heart Failure, Renal Disease, CV Risk Research is on Fire
George Bakris, MD
Professor of Medicine, University of Chicago,
Director, Comprehensive Hypertension Center,
University of Chicago Medicine
John B. Buse, MD, PhD
Distinguished Professor,
Chief of the Division of Endocrinology,
Director of the Diabetes Center,
University of North Carolina School of Medicine at Chapel Hill
EHR-integrated Remote Monitoring of Hypertension: A Pilot Study in Primary Care
Stephen Persell, MD, MPH
Professor of Medicine, Division of General Internal Medicine and Geriatrics,
Northwestern University Feinberg School of Medicine,
Director, Center for Primary Care Innovation,
Northwestern Medicine
Tests of Clinical Knowledge
- 8 Questions on Diabetes Drugs for Cardioprotection
- Nocturnal Hypertension: 8 Essential Questions
- A Heart Failure Research Roundup Quiz: 8 Questions
Slideshows - Education At-a-Glance
- Hypertension, Renal, & Hepatic Disease: A 10-question Collection for Primary Care
- White Coat Hypertension & Masked Hypertension: A Primary Care Primer
- ACC/AHA 2021 Chest Pain Evaluation & Diagnosis Guidelines: Top 10 Take-homes
- Fundamentals of CVD Risk Assessment: Guideline Topline for Primary Care
- 9 Prime CVD Prevention Pointers from the ACC/AHA 2019 Primary Prevention Guideline
- Diabetes Drugs and Cardioprotection: A Summary for Primary Care
- ACC/AHA 2021 Chest Pain Evaluation & Diagnosis Guidelines: Top 10 Take-homes
- Heart Failure Drugs in the Pipeline: Six Novel Therapeutics to Note
- Role of Primary Care in Poststroke Care: 6 Takeaways from New AHA/ASA Scientific Statement
- Mental Health & Cardiovascular Disease: What's the Link?
- AHA Statement on Obesity and CVD: 10 Key Points, to Start
- ACP: ASCVD Risk Estimation for Primary Prevention with Donald Lloyd-Jones, MD, ScM
- ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment
- 8 Hypertension Research Recaps for Primary Care
- Heart Failure Milestones in Management: 9 Studies Making a Difference in 2021
- The Framingham Heart Study: Research to Clinical Practice Timeline
- Framingham Heart Study in the New Millennium: Deeper Dives into CVD Risk
- Social Determinants of Health and ASCVD Prevention: Clinical Considerations
FDA Decisions
- Empagliflozin FDA-approved for Heart Failure with Reduced Ejection Fraction
- FDA Grants Label Expansion for Heart Failure Treatment
- FDA Approves Novel Agent for Treatment of Heart Failure
Conference Roundup
American Heart Association Scientific Sessions
November 13-15, 2021
- Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials
- First Sign of CVD in Smokers May be a Fatal MI or Stroke, New Study Finds
- Canagliflozin Improved HF Symptoms, QOL Regardless of Diabetes Status in Fully Remote Clinical Trial
- Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients
- Novel Fitbit Algorithm Correctly Detected Undiagnosed Atrial Fibrillation
- Coffee Had Negligible Effect on Atrial Arrhythmias but Was Linked to PVCs, Study Finds
- Population for Digital Heart Failure Coaching App May Need Rethinking
- Study Highlights Factors that Influence Patient Engagement with Remote CVD Risk Reduction Intervention
- Automated Statin-associated Muscle Symptom Tracker May Help Tailor Therapy, Improve Adherence
- Effective BP Reduction Achieved via Hypertension Remote Care Program During Lockdown
- Living in More Socially Vulnerable Neighborhood Linked to Worse Outcomes in Hospitalized COVID-19 Patients
- Risk of Early Stroke Increased in Adults who Vape vs Smoke Traditional Cigarettes, Study Finds
- Young Black Adults Experienced Rising Burden of CVD Risk Factors, Worse Hospital Outcomes in 10-year Study
European Society of Cardiology Congress 2021
August 27-30, 2021
- European Society of Cardiology Congress 2021: Primary Care Preview
- ESC 2021: Flu Vaccine Cuts Risk of Death, Heart Attack in Patients with Heart Disease
- Major Hypertension Trial Supports Tight BP Control with Data from Older Adults
- Low-sodium Salt Alternative Found to Reduce Risk of Stroke
- Finerenone Now Shows Promise in Less Severe Diabetic Kidney Disease
- ESC 2021: Empagliflozin Found Beneficial in Patients with Heart Failure Regardless of Ejection Fraction
- ESC 2021: EMPORER-Preserved: Empagliflozin Reduces Composite CV Endpoint in HFpEF
- New Study Suggests Link Between Saturated Fat and CVD Risk Varies by Food Source
- ESC 2021: Patients with Prior Myocardial Infarction and Gum Disease Face Higher Risk of Heart Disease
- ESC 2021: Despite Smoking Less, Women Find it Harder to Quit Than Men
- ESC 2021: The Risk of Young-onset Heart Attack May Go Beyond Family History
American College of Cardiology Scientific Sessions
May 15-17, 2021
- ACC.21: High- and Low-Dose Aspirin Both Effective for Patients with Established Cardiovascular Disease
- Survival After MI Far Worse for Black Patients from Disadvantaged Neighborhoods
- ACC.21: Prediabetes Significantly Increases Risk for MACE, According to New Findings
- Black Women at Risk Early in Life for Future Cardiovascular Disease
